Zimmer Partners’s Generation Bio GBIO Stock Holding History

Zimmer Partners’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,500	Closed	-$525K	–	137
2020 Q2	$525K	Buy	+2,500	New	+$557K	0.01%	103

Other funds holding GBIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Zimmer Partners's GBIO Position: Q3 2020 in Review

Zimmer Partners sold out of Generation Bio (GBIO) in Q3 2020, closing a stake of 2,500 shares — an estimated $525K sold.

Zimmer Partners first reported a position in GBIO in Q2 2020 and held it in 1 quarter. The position peaked at $525K in Q2 2020. 53 funds tracked by Wall St. Rank hold GBIO as of Q3 2020.

Zimmer Partners reported no remaining Generation Bio position as of Q3 2020 after selling out during the quarter.
Zimmer Partners sold 2,500 Generation Bio shares in Q3 2020, an estimated $525K.
Zimmer Partners first reported a position in Generation Bio in Q2 2020 and held it in 1 quarter.
Zimmer Partners's Generation Bio position peaked at $525K in Q2 2020.
53 funds tracked by Wall St. Rank held Generation Bio as of Q3 2020.

Based on Zimmer Partners's 13F filing for Q3 2020, filed 16 Nov 2020.